BEAM
Price
$17.41
Change
+$0.16 (+0.93%)
Updated
May 9 closing price
Capitalization
1.73B
94 days until earnings call
HOWL
Price
$0.80
Change
-$0.07 (-8.05%)
Updated
May 9 closing price
Capitalization
39.04M
89 days until earnings call
Ad is loading...

BEAM vs HOWL

Header iconBEAM vs HOWL Comparison
Open Charts BEAM vs HOWLBanner chart's image
Beam Therapeutics
Price$17.41
Change+$0.16 (+0.93%)
Volume$2.38M
Capitalization1.73B
Werewolf Therapeutics
Price$0.80
Change-$0.07 (-8.05%)
Volume$188.06K
Capitalization39.04M
BEAM vs HOWL Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. HOWL commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and HOWL is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (BEAM: $17.41 vs. HOWL: $0.80)
Brand notoriety: BEAM and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 90% vs. HOWL: 74%
Market capitalization -- BEAM: $1.73B vs. HOWL: $39.04M
BEAM [@Biotechnology] is valued at $1.73B. HOWL’s [@Biotechnology] market capitalization is $39.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and HOWL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while HOWL’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • HOWL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than HOWL.

Price Growth

BEAM (@Biotechnology) experienced а -13.98% price change this week, while HOWL (@Biotechnology) price change was -11.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

HOWL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.74B) has a higher market cap than HOWL($39M). BEAM YTD gains are higher at: -29.798 vs. HOWL (-45.959). HOWL has higher annual earnings (EBITDA): -64.05M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. HOWL (111M). HOWL has less debt than BEAM: HOWL (37.1M) vs BEAM (161M). BEAM has higher revenues than HOWL: BEAM (63.5M) vs HOWL (1.89M).
BEAMHOWLBEAM / HOWL
Capitalization1.74B39M4,449%
EBITDA-383.98M-64.05M600%
Gain YTD-29.798-45.95965%
P/E RatioN/AN/A-
Revenue63.5M1.89M3,369%
Total Cash851M111M767%
Total Debt161M37.1M434%
TECHNICAL ANALYSIS
Technical Analysis
BEAMHOWL
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NODK12.560.37
+2.99%
NI Holdings
OMCL25.780.39
+1.54%
Omnicell
CTNT1.38N/A
N/A
Cheetah Net Supply Chain Service Inc
CADE30.72-0.03
-0.10%
Cadence Bank
TRV269.75-1.07
-0.40%
Travelers Companies (The)

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-8.07%
GBIO - HOWL
43%
Loosely correlated
+0.06%
AURA - HOWL
40%
Loosely correlated
-9.83%
ATOS - HOWL
39%
Loosely correlated
+0.85%
IPSC - HOWL
38%
Loosely correlated
+3.27%
ABOS - HOWL
37%
Loosely correlated
-1.99%
More